Product Research
Paclitaxel
Docetaxel
Vinorelbine
Ifosfamide
Mesna
Pirarubicin
Aclarubicin
Adriamycin
Daunorubicin
Vincristine
Bleomycin
Lastet



 

Mesnaum injection (Mesna) can combine with acrolein into nontoxic compound by its hydrosulfide group (SH), It can combine with 4-OH-cyclophosphamide and 4-OH-iphosphamide to avoid cystitis. As a protective agent of urinary tract, Mesna can be applied to avoid toxicity of urinary system epithelium such as hemorrhagic cystitis when using high dose of iphosphamide or cyclophosphamide to cure tumor.

Mesna is mainly applied to combine with cyclophosphamide or iphosphamide, so as to avoid hemorrhagic cystitis.



 
  国家食品药品监督管理局世界卫生组织中国医学科学院深圳万维医药贸易有限公司  
  深圳万乐药业有限公司 版权所有
Copyright © 2004 Shenzhen Main Luck Phar maceuticals Inc. All right reserved
Email:wanle@wanle.com.cn
 
Home Site Map English Version